Search clinical trials for: epirubicin cyclophosphamide

Total 4060 results

Harlachinger Krebshilfe e.V.
Deutsche AIDS Gesellschaft e.V.

Unknown

Prospective Study on HIV-related Hodgkin Lymphoma

HIV-associated Hodgkin Lymphoma

Germany
M.D. Anderson Cancer Center

Completed

Autologous Transplantation for Chronic Myelogenous Leukemia

Chronic Myelogenous Leukemia

United States
M.D. Anderson Cancer Center

Completed

Safety and Efficacy of Campath in Nonmyeloablative Transplantation

Lymphoma | Leukemia

United States
M.D. Anderson Cancer Center

Completed

Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia

Aplastic Anemia

United States
Shanghai CP Guojian Pharmaceutical Co., Ltd.

Completed

Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma

Diffuse Large B Cell Lymphoma

China
Columbia University

Unknown

Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases

Severe Combined Immunodeficiency | Fanconi Anemia | Bone Marrow Failure | Osteopetrosis

United States
Fondazione Italiana Linfomi ONLUS

Unknown

Study With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet®), Vincristine, Prednisone, (R-COMP) to Treat Non-Hodgkin's Lymphoma

Diffuse Large B-Cell Lymphoma

Italy
TTY Biopharm

Unknown

Lipo-dox and Cyclophosphamide /5-Fluorouracil in Patients With Metastatic Breast Cancer

Metastatic Breast Cancer

Taiwan
St. Jude Children's Research Hospital
National Cancer Institute (NCI)

Completed

Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma

Retinoblastoma

United States
Nanjing University School of Medicine

Completed

Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V)

Lupus Nephritis

China
Chonnam National University Hospital

Unknown

Early Response-adapted Intensification of Induction Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma (MM) (KMM-97)

Multiple Myeloma

Korea, Republic of
PETHEMA Foundation

Completed

Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma (TaCyDexVMP7)

Multiple Myeloma

Spain
Radboud University Medical Center

Unknown

MIBG Scintigraphy and Strain Echocardiography in the Detection of Subclinical Cardiovascular Effects One Year After (Neo)Adjuvant Breast Cancer Treatment With Docetaxel, Doxorubicin and Cyclophosphamide (TAC): a Pilot Study (TOXTAC)

Breast Cancer

Netherlands
Assistance Publique - Hôpitaux de Paris

Completed

Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years (CORTAGE)

Vasculitis | Wegener's Granulomatosis | Microscopic Polyangiitis | Churg-Strauss Syndrome | Polyarteritis Nodosa

France
Chang Gung Memorial Hospital

Unknown

Botulinum Toxin to Improve Results in Cleft Lip Repair

Scar

Taiwan
Mayo Clinic
National Cancer Institute (NCI)

Completed

Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Northwestern University
National Cancer Institute (NCI)

Completed

Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Lymphoma

United States
University of Yamanashi

Unknown

Study of Chemo-Immunotherapy in Head and Neck Cancer Patients

Head and Neck Cancer

Japan
Zhejiang University

Completed

Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis

Renal Insufficiency | Lupus Nephritis | SLE | End-stage Renal Disease
National Cancer Institute (NCI)

Completed

Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes

Anti-p53 TCR-Gene

United States
Peking Union Medical College Hospital

Unknown

AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer

Breast Cancer

China
University of Cologne

Completed

Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma

Hodgkin´s Lymphoma

Germany
Taiho Pharmaceutical Co., Ltd.

Completed

A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)

Breast Cancer

Japan
Dana-Farber Cancer Institute

Completed

A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer

Neoplasms

United States
Taiho Pharmaceutical Co., Ltd.

Completed

The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)

Breast Cancer

Japan
Herlev Hospital
Odense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark

Completed

Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast Cancer

Breast Cancer

Denmark
Fudan University

Completed

Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer

Gastric Cancer

China
Sanofi

Completed

Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer Patients (SATIN)

Breast Neoplasms

France, Brazil, Poland, Germany, Belgium, Tunisia, United Kingdom, Uruguay
National Cancer Center, Korea

Completed

Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer

Breast Cancer
Kyushu University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors (peptidevac)

Metastatic Tumors

Japan
Mayo Clinic
National Cancer Institute (NCI)

Completed

Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States, Canada
Mayo Clinic
National Cancer Institute (NCI)

Completed

Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer

Breast Cancer
Institut Bergonié

Completed

MRI in Evaluating Early Response to Chemotherapy in Women Receiving Chemotherapy for Infiltrating Breast Cancer

Breast Cancer

France
Hoag Memorial Hospital Presbyterian
Cancer Biotherapy Research Group

Completed

Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma

Lymphoma | Leukemia

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse

Multiple Myeloma and Plasma Cell Neoplasm

United States
University of Liverpool
Roche Pharma AG; Cancer Research UK; Liverpool University Hospitals NHS Foundation...

Unknown

A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients (PACIFICO)

Follicular Lymphoma

United Kingdom
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy of Steroid Versus Steroid Plus Cyclophosphamide for Severe Henoch-Schoenlein Purpura

Henoch-Schoenlein Purpura

France
SCRI Development Innovations, LLC
Aventis Pharmaceuticals; Pharmacia and Upjohn

Terminated

Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer

Breast Cancer
SCRI Development Innovations, LLC
Aventis Pharmaceuticals

Completed

Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer

Breast Cancer
New York Presbyterian Hospital

Completed

The Impact of Botox® During Robotic Rehabilitation of the Wrist Following Stroke

Stroke

United States
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Completed

THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)

Multiple Myeloma
Tel-Aviv Sourasky Medical Center

Unknown

Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)

Juvenile Myelomonocytic Leukemia | Myelodysplastic Syndrome | Acute Leukemias | Chronic Leukemias
Dutch Childhood Oncology Group
St. Jude Children's Research Hospital; International BFM Study Group

Completed

Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
Ann & Robert H Lurie Children's Hospital of Chicago

Unknown

Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies

Lymphoma, Malignant | Leukemia, Myelogenous, Chronic | Leukemia, Lymphoblastic, Acute | Leukemia, Myelogenous, Acute | Myeloproliferative-Myelodysplastic Diseases

United States
St. Jude Children's Research Hospital

Terminated

Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

United States
NYU Langone Health
National Cancer Institute (NCI)

Completed

Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

Breast Cancer

United States
Sun Yat-sen University
Fudan University; West China Hospital; Peking University Cancer Hospital & Institute and other collaborators

Unknown

Combination of Bortezomib, Fludarabine and Cyclophosphamide Treat Recurrent Mantle Cell Lymphoma

Mantle Cell Lymphoma Recurrent

China
University Hospital, Clermont-Ferrand
Merz Pharmaceuticals

Unknown

Foot Dystonia Treatment by Botulinum Toxin Injections in Parkinson Disease : Efficiency of Injections Made in Extrinsic Muscle (Flexor Digitorum Longus Muscle) Compared to Intrinsic Muscle (Flexor Digitorum Brevis or Quadratus Plantae Muscles) (RBHP 2008)

Parkinson's Disease | Foot Dystonia

France
Georgetown University
National Cancer Institute (NCI)

Completed

Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Hospital Universitario Madrid Sanchinarro

Unknown

Bevacizumab and Trastuzumab With Weekly Paclitaxel Followed, After Surgery, by Encapsuled Liposomal Doxorubicin, Cyclophosphamide and Trastuzumab as Adjuvant Treatment After Surgery on Women With Her2+ Breast Cancer

Breast Cancer

Spain

3

Subscribe